Allergy Therapeutics plc (AIM: AGY)
4.180
-0.120 (-2.79%)
Sep 11, 2024, 12:59 PM GMT+1
Allergy Therapeutics Revenue
Allergy Therapeutics had revenue of 33.57M GBP in the half year ending December 31, 2023, a decrease of -31.06%. This brings the company's revenue in the last twelve months to 53.26M, down -16.75% year-over-year. In the fiscal year ending June 30, 2023, Allergy Therapeutics had annual revenue of 59.59M, down -18.11%.
Revenue (ttm)
53.26M
Revenue Growth
-16.75%
P/S Ratio
1.37
Revenue / Employee
87.02K
Employees
612
Market Cap
204.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 59.59M | -13.18M | -18.11% |
Jun 30, 2022 | 72.77M | -11.56M | -13.71% |
Jun 30, 2021 | 84.33M | 6.13M | 7.83% |
Jun 30, 2020 | 78.20M | 4.49M | 6.09% |
Jun 30, 2019 | 73.72M | 5.37M | 7.86% |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Jun 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAllergy Therapeutics News
- 2 months ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 2 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 4 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz